Karanth S, et al. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. JAMA Neurol. 2020;77(10):1299–307.

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Cordero I, et al. Evaluating the Effect of Alzheimer’s Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy. Ann Neurol. 2024;96(1):99–109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh NA, et al. Relationships between PET and blood plasma biomarkers in corticobasal syndrome. Alzheimers Dement. 2024;20(7):4765–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palleis C, et al. Association Neurofilament Light Chain [Neurology. 2024;102(1):e207901.

Google Scholar 

Benvenutto A, et al. Clinical Phenotypes in Corticobasal Syndrome with or without Amyloidosis Biomarkers. J Alzheimers Dis. 2020;74(1):331–43.

Article  PubMed  Google Scholar 

Malfertheiner K, Stefanova N, Heras-Garvin A. The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders. Front Neurol. 2021;12:737195.

Article  PubMed  PubMed Central  Google Scholar 

Araki K, et al. The secondary structural difference between Lewy body and glial cytoplasmic inclusion in autopsy brain with synchrotron FTIR micro-spectroscopy. Sci Rep. 2020;10(1):19423.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, et al. Prion-Like Mechanisms in Parkinson’s Disease. Front Neurosci. 2019;13:552.

Article  PubMed  PubMed Central  Google Scholar 

Graves NJ, Gambin Y, Sierecki E. α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies. Int J Mol Sci, 2023. 24(15). https://doi.org/10.3390/ijms241512134

Caillet-Boudin ML, et al. Regulation of human MAPT gene expression. Mol Neurodegener. 2015;10:28.

Article  PubMed  PubMed Central  Google Scholar 

Mietelska-Porowska A, et al. Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci. 2014;15(3):4671–713.

Article  PubMed  PubMed Central  Google Scholar 

Stamelou M, et al. Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol. 2021;17(10):601–20.

Article  PubMed  Google Scholar 

Strang, K. H., Golde, T. E., & Giasson, B. I. (2019). MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Laboratory Investigation, 99(7), 912–28.

Article  PubMed  PubMed Central  Google Scholar 

Meyer PF, et al. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography. JAMA Neurol. 2020;77(4):508–16.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, et al. Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer’s disease in clinical and community cohorts. Alzheimers Dement. 2025;21(3):e70038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jack CR, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.

Article  PubMed  PubMed Central  Google Scholar 

Teunissen, C. E., & Vermunt, L. (2025). Implications of AD plasma and PET biomarker discordance. Nature Reviews Neurology, 21(6), 295–6.

Article  CAS  PubMed  Google Scholar 

Kuang Y, et al. α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation. Transl Neurodegener. 2024;13(1):56.

Article  PubMed  PubMed Central  Google Scholar 

Martinez-Valbuena I, et al. Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy. JAMA Neurol. 2024;81(11):1228–30. https://doi.org/10.1001/jamaneurol.2024.3162

Article  PubMed  PubMed Central  Google Scholar 

Martinez-Valbuena I, et al. Combining Skin α-Synuclein Real-Time Quaking-Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson’s Disease. Mov Disord. 2022;37(3):648–50.

Article  CAS  PubMed  Google Scholar 

Shahnawaz M, et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy. Nature. 2020;578(7794):273–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scialò C, et al. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun. 2020;2(2):fcaa142.

Article  PubMed  PubMed Central  Google Scholar 

Jack CR, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement. 2024;20(8):5143–69.

Article  PubMed  PubMed Central  Google Scholar 

Irwin DJ, et al. Evolution of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers in Early Parkinson’s Disease. Ann Neurol. 2020;88(3):574–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baek MS, et al. Temporal trajectory of biofluid markers in Parkinson’s disease. Sci Rep. 2021;11(1):14820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nabizadeh, F., Sodeifian, F., & Kargar, A. (2023). Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson’s disease. Acta Neurologica Belgica, 123(4), 1429–37.

Article  PubMed  Google Scholar 

Pilotto A, et al. Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease. J Neurol. 2024;271(12):7537–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bäckström D, et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. Brain Commun. 2022;4(2):fcac040.

Article  PubMed  PubMed Central  Google Scholar 

Tufekcioglu Z, et al. Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta. Dement Geriatr Cogn Dis Extra. 2023;13(1):39–47.

Article  PubMed  PubMed Central  Google Scholar 

Chen NC, et al. Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease. Front Aging Neurosci. 2020;12:112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hatcher-Martin JM, et al. Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis. NPJ Parkinsons Dis. 2021;7(1):105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batzu L, et al. Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease. NPJ Parkinsons Dis. 2022;8(1):154.

Article  CAS  PubMed